Adherence to dosing instructions in simulated OTC environment

This study reviews the adherence of US consumers to proposed label directions for a new 400 mg ibuprofen formulation. In this 30-day study simulating an over-the-counter (OTC)-like environment, US analgesic consumers reviewed proposed product packaging for a new 400 mg ibuprofen formulation and made a purchase decision. Purchasers used the product as needed and recorded use over 30 days.
This study provides evidence that a majority of US consumers would be able to use OTC ibuprofen 400 mg tablets in a manner consistent with product labeling. Misuse rates were low and unlikely to generate an excess risk of clinically important adverse events (Int. Journal of Clinical Pharmacology, July 2017).
Click here for an abstract of the article about the research.
Click here for more information about the NVC project Pharmaceutical Packaging.

This news item is also included in our monthly overview, the NVC Members-only Update. If you have any questions, please contact us: info@nvc.nl, +31-(0)182-512411.